CD4 News and Research

RSS
Could the intranasal route be an alternate avenue of COVID-19 vaccination?

Could the intranasal route be an alternate avenue of COVID-19 vaccination?

Repeated low-dose dose exposure to SARS-CoV-2 may protect against severe COVID-19

Repeated low-dose dose exposure to SARS-CoV-2 may protect against severe COVID-19

Could sustained inflammation following mild to moderate COVID-19 be a driver of long COVID?

Could sustained inflammation following mild to moderate COVID-19 be a driver of long COVID?

Maternal SARS-CoV-2 infection imprints immune response in the newborn

Maternal SARS-CoV-2 infection imprints immune response in the newborn

Heterologous AstraZeneca and Pfizer vaccines induce strong immune response and T cell reactivity against multiple SARS-CoV-2 variants

Heterologous AstraZeneca and Pfizer vaccines induce strong immune response and T cell reactivity against multiple SARS-CoV-2 variants

Large-scale expansion of spike-reactive T cells feasible after COVID-19 vaccination

Large-scale expansion of spike-reactive T cells feasible after COVID-19 vaccination

New vaccine candidate with RBD and N protein targets protects against SARS-CoV-2 in preclinical trials

New vaccine candidate with RBD and N protein targets protects against SARS-CoV-2 in preclinical trials

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

A novel multi-epitope COVID-19 vaccine developed using reverse vaccinology

A novel multi-epitope COVID-19 vaccine developed using reverse vaccinology

Intensity and duration of SARS-CoV-2 immunity may depend on ABO blood group

Intensity and duration of SARS-CoV-2 immunity may depend on ABO blood group

Tissue-resident memory T cells found in lungs of people who had COVID-19 10 months ago

Tissue-resident memory T cells found in lungs of people who had COVID-19 10 months ago

An exploratory study of T-cell and antibody responses after COVID-19 mRNA vaccination

An exploratory study of T-cell and antibody responses after COVID-19 mRNA vaccination

Immunologists decode T cell responses that occur during COVID-19 infection

Immunologists decode T cell responses that occur during COVID-19 infection

Human T cells can target more than 1,400 sites on SARS-CoV-2 virus

Human T cells can target more than 1,400 sites on SARS-CoV-2 virus

Next-generation SARS-CoV-2 subunit vaccine candidate elicits powerful immunity in preclinical trials

Next-generation SARS-CoV-2 subunit vaccine candidate elicits powerful immunity in preclinical trials

Facets of SARS-CoV-2 infection and animal models

Facets of SARS-CoV-2 infection and animal models

Are COVID-19-related complications in children explained by abnormal immune responses?

Are COVID-19-related complications in children explained by abnormal immune responses?

COVID-19 mRNA vaccines safe and effective for pregnant and breastfeeding women

COVID-19 mRNA vaccines safe and effective for pregnant and breastfeeding women

Moderna and Pfizer-BioNTech vaccines induce robust T cell response against SARS-CoV-2 variants

Moderna and Pfizer-BioNTech vaccines induce robust T cell response against SARS-CoV-2 variants

Unique pre-clinical model enables study of HIV infection and testing of new therapies

Unique pre-clinical model enables study of HIV infection and testing of new therapies